Medullary Thyroid Cancer
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | RET oncogenic variants | Medullary Thyroid Cancer | Selpercatinib | |
| EMA (1) | v::RET | Medullary Thyroid Cancer | Vandetanib | |
| EMA (1) | RET p.M918T | Medullary Thyroid Cancer | Selpercatinib |